EUVIMEDEUVIMED entdecken
Crossref

Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong

Wang Chun Kwok iD, Terence Chi Chun Tam iD, Chor Wing Sing iD, Esther Wai Yin Chan iD, Ching-Lung Cheung iD

Pharmacoepidemiology and Drug Safety · 2023

DOI: 10.1002/pds.5638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2023. Verfasst von Wang Chun Kwok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Electronic Health Records, Clinical Coding. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Electronic medical record (EMR) databases can facilitate epidemiology research in various diseases including bronchiectasis. Given the diagnostic challenges of bronchiectasis, the validity of the coding in EMR requires clarification. We aimed to assess the validity of International Classification of Diseases, 9th Revision (ICD‐9) code algorithms for identifying bronchiectasis in the territory‐wide electronic medical health record system of Clinical Data Analysis and Reporting System (CDARS) in Hong Kong. Materials and Methods Adult patients who had the diagnosis of bronchiectasis input from Queen Mary Hospital in 2011–2020 were identified using the ICD‐9 code of 494 by CDARS. All patients who had high resolution computed tomography (HRCT) were reviewed by respiratory specialists to confirm the presence of bronchiectasis on HRCT.

Results

A total of 19 617 patients who had the diagnostic code of bronchiectasis among all public hospitals in Hong Kong and 1866 in Queen Mary Hospital in the same period. Six hundred and forty‐eight cases were randomly selected and validated using medical record and HRCT review by a respiratory specialist. The overall positive predictive value (PPV) was 92.7% (95% CI 90.7–94.7).

Conclusions

This was the first ICD‐9 coding validation for bronchiectasis in Hong Kong CDARS. Our study demonstrated that using ICD‐9 code of 494 was reliable to support utility of CDARS database for further clinical research on bronchiectasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsClinical CodingAdultHumansHong KongSoftwareAlgorithmsInternational Classification of Diseases

Stichwörter der Autor:innen

EHRalgorithmsbronchiectasiselectronic health recordvalidation

Autor:innen und Institutionen

  • Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
  • Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Wang Chun Kwok, Terence Chi Chun Tam, Chor Wing Sing, Esther Wai Yin Chan, Ching-Lung Cheung

Zitieren

APA

Kwok, W. C., Tam, T. C. C., Sing, C. W., Chan, E. W. Y., & Cheung, C. L. (2023). Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5638

Vancouver

Kwok WC, Tam TCC, Sing CW, Chan EWY, Cheung CL. Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong. Pharmacoepidemiology and Drug Safety. 2023. doi:10.1002/pds.5638

BibTeX
@article{Kwok2023,
  author = {Kwok, Wang Chun and Tam, Terence Chi Chun and Sing, Chor Wing and Chan, Esther Wai Yin and Cheung, Ching-Lung},
  title = {Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2023},
  doi = {10.1002/pds.5638}
}
Kostenlos starten →